Clinical Trial Update: Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating pemetrexed plus cisplatin for malignant pleural mesothelioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• Cisplatin (Platinol) (cisplatin)
• Pemetrexed (Alimta) (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Malignant Pleural Mesotherioma | Phase 1, Phase 2 | Status: COMPLETED